Post-doctoral Training Program in Cancer Metabolism and Tumor-host Interactions
癌症代谢和肿瘤宿主相互作用博士后培训项目
基本信息
- 批准号:10375556
- 负责人:
- 金额:$ 31.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2023-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Rutgers Cancer Institute of New Jersey (RCINJ) provides an outstanding environment for training in basic,
clinical, behavioral or population-based cancer research and brings together an exceptional group of
investigators organized in multi-disciplinary research teams focusing on a broad spectrum of cancer research.
The Cancer Metabolism and Growth (CMG) Program, at RCINJ has robust research strengths bolstered by
strong collaboration between researchers at Rutgers and our formal consortium partner Princeton University.
The proposed program leverages these unique research strengths and resources of RCINJ to provide training
in translational research in Cancer Metabolism and Growth and Tumor Host Interactions. The primary
goal of this T32 training program is to provide postdoctoral candidates with the highest quality training and
research experience so that they are competitive in developing research careers in academia, government,
and the private sector. To achieve this goal, trainees will engage in mentored cancer research, co-curricular
and professional career development activities for two years. Program candidates are Ph.D. recipients who
wish to develop careers in cancer research. The program will recruit a cohort of 2 new trainees each year from
year 1-5. Thus, the program will have 2 trainees in year 1 and 4 trainees in year 2 through 5 of the training
grant. High achieving post-doctoral fellows (evidenced by research productivity in the form of number of
publications, fellowship awards, presentations etc.), may be supported for an additional third year of training
through institutional funds. Faculty members with active, well-funded research programs and extensive
mentoring experience will support program trainees. All of the faculty mentors chosen for this program have
significant R01-level peer reviewed funding in tumor metabolism and host interactions focused research.
Experienced leadership team with track-record of research productivity and mentoring will ensure successful
implementation of the program. Both formative and summative evaluation will be integral parts of the proposed
program. We will annually track the educational and professional activities of trainees for at least 10 years
after completing research training. We will disseminate results from the comprehensive evaluation on the
program website. Additional dissemination will occur through articles published in peer-reviewed journals and
through presentations at regional and national conferences, by program staff as well as participants. Our
program benefits from the multi-disciplinary research environment and robust educational resources available
at RCINJ (the state's only NCI designated Comprehensive Cancer Center) as well as the consortium
relationship with Princeton University.
19
罗格斯癌症研究所新泽西(RCINJ)提供了一个优秀的环境,培训的基础,
临床,行为或基于人群的癌症研究,并汇集了一个特殊的群体,
研究人员组成多学科研究小组,专注于广泛的癌症研究。
癌症代谢和生长(CMG)计划,在RCINJ具有强大的研究实力,
罗格斯大学的研究人员和我们的正式合作伙伴普林斯顿大学之间的密切合作。
拟议的计划利用这些独特的研究优势和资源的RCINJ提供培训
癌症代谢和生长以及肿瘤宿主相互作用的转化研究。主
该T32培训计划的目标是为博士后候选人提供最高质量的培训,
研究经验,使他们在学术界,政府,
和私营部门。为了实现这一目标,学员将参与指导癌症研究,
职业生涯发展计划为期两年。计划候选人是博士。受助人
希望在癌症研究方面发展事业。该计划每年将招募2名新学员,
年1-5。因此,该计划将有2名学员在第1年和4名学员在第2年至第5年的培训
格兰特.高成就的博士后研究员(以研究生产力的形式证明,
出版物、研究金、演讲等),可以支持额外的第三年培训
通过机构资金。教师积极,资金充足的研究计划和广泛的
指导经验将支持计划学员。所有为这个项目选择的教师导师都有
重要的R 01级同行评审的资金在肿瘤代谢和宿主相互作用为重点的研究。
经验丰富的领导团队与跟踪记录的研究生产力和指导将确保成功
方案的实施。形成性评价和总结性评价都将是拟议的
程序.我们将每年跟踪学员的教育和专业活动至少10年
完成研究训练后。我们将传播对《公约》的全面评价结果,
节目网站。将通过在同行评审期刊上发表的文章进行额外传播,
通过方案工作人员和参与者在区域和国家会议上的发言。我们
计划受益于多学科的研究环境和强大的教育资源可用
在RCINJ(该州唯一的NCI指定的综合癌症中心)以及财团
与普林斯顿大学的关系。
19
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yibin Kang其他文献
Yibin Kang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yibin Kang', 18)}}的其他基金
Post-doctoral Training Program in Cancer Metabolism and Tumor-host Interactions
癌症代谢和肿瘤宿主相互作用博士后培训项目
- 批准号:
10596510 - 财政年份:2021
- 资助金额:
$ 31.47万 - 项目类别:
Jagged1-dependent tumor-stromal interactions in bone metastasis
骨转移中Jagged1依赖性肿瘤-基质相互作用
- 批准号:
10064995 - 财政年份:2017
- 资助金额:
$ 31.47万 - 项目类别:
Jagged1-dependent tumor-stromal interactions in bone metastasis
骨转移中Jagged1依赖性肿瘤-基质相互作用
- 批准号:
9218934 - 财政年份:2017
- 资助金额:
$ 31.47万 - 项目类别:
The Role of miRNAs in Epithelial-Mesenchymal Transition and Metastasis
miRNA 在上皮-间质转化和转移中的作用
- 批准号:
8054922 - 财政年份:2010
- 资助金额:
$ 31.47万 - 项目类别:
The Role of miRNAs in Epithelial-Mesenchymal Transition and Metastasis
miRNA 在上皮-间质转化和转移中的作用
- 批准号:
8607149 - 财政年份:2010
- 资助金额:
$ 31.47万 - 项目类别:
The Role of miRNAs in Epithelial-Mesenchymal Transition and Metastasis
miRNA 在上皮-间质转化和转移中的作用
- 批准号:
8447363 - 财政年份:2010
- 资助金额:
$ 31.47万 - 项目类别:
The Role of miRNAs in Epithelial-Mesenchymal Transition and Metastasis
miRNA 在上皮-间质转化和转移中的作用
- 批准号:
7899330 - 财政年份:2010
- 资助金额:
$ 31.47万 - 项目类别:
The Role of miRNAs in Epithelial-Mesenchymal Transition and Metastasis
miRNA 在上皮-间质转化和转移中的作用
- 批准号:
8264374 - 财政年份:2010
- 资助金额:
$ 31.47万 - 项目类别:
Metadherin in Metastasis and Chemoresistance of Breast Cancer
美粘素在乳腺癌转移和化疗耐药中的作用
- 批准号:
8127696 - 财政年份:2008
- 资助金额:
$ 31.47万 - 项目类别:
Metadherin in Metastasis and Chemoresistance of Breast Cancer
美粘素在乳腺癌转移和化疗耐药中的作用
- 批准号:
7694278 - 财政年份:2008
- 资助金额:
$ 31.47万 - 项目类别:














{{item.name}}会员




